43 results on '"Miravitlles, Marc"'
Search Results
2. Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project
3. Implementing an Evidence-Based COPD Hospital Discharge Protocol: A Narrative Review and Expert Recommendations
4. Effect of different types of supervised exercise programs on cardiorespiratory and muscular fitness, pain, fatigue, mental health and inflammatory and oxidative stress biomarkers in older patients with post-COVID-19 sequelae “EJerSA-COVID-19”: a randomized controlled trial
5. Poor sleep quality, COPD severity and survival according to CASIS and Pittsburgh questionnaires
6. The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
7. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
8. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
9. Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain
10. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study
11. Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis
12. New variants of alpha-1-antitrypsin: structural simulations and clinical expression
13. Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis
14. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
15. Impaired pulmonary and muscle function during moderate exercise in female patients recovered from SARS-CoV-2
16. Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database
17. Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO® Trials
18. Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
19. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis
20. Correction to: Association between circulating alpha-1 antitrypsin polymers and lung and liver disease
21. Association between circulating alpha-1 antitrypsin polymers and lung and liver disease
22. Ischiocrural Strength May Be a Better Prognostic Marker Than Quadriceps Strength in COPD
23. Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
24. Tiotropium in chronic obstructive pulmonary disease – a review of clinical development
25. Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial
26. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
27. Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management
28. Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care
29. What have we learned from observational studies and clinical trials of mild to moderate COPD?
30. Alpha-1 antitrypsin deficiency: outstanding questions and future directions
31. Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease
32. Factors Associated with Depression in COPD: A Multicenter Study
33. Muscular Dysfunction in COPD: Systemic Effect or Deconditioning?
34. Factors Associated with a Low Level of Physical Activity in Patients with Chronic Obstructive Pulmonary Disease
35. Clinical Outcomes and Cost Analysis of Exacerbations in Chronic Obstructive Pulmonary Disease
36. Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain
37. Valor umbral del coste por año de vida ganado para recomendar la adopción de tecnologías sanitarias en España: evidencias procedentes de una revisión de la literatura
38. Determining Factors in the Prescription of Moxifloxacin in Exacerbations of Chronic Bronchitis in the Primary-Care Setting
39. Exacerbations, Hospital Admissions and Impaired Health Status in Chronic Obstructive Pulmonary Disease
40. Erratum to: Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management
41. Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: A review of the literature
42. Effect of Various Antimicrobial Regimens on the Clinical Course of Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary Disease in Primary Care
43. Speed of Recovery from Acute Exacerbations of Chronic Obstructive Pulmonary Disease after Treatment with Antimicrobials: Results of a Two-Year Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.